AstraZeneca Announces Record 15 Billion Dollar Investment in China Through 2030
AstraZeneca plans to invest 15 billion dollars in China by 2030 to boost manufacturing and research. The record commitment was announced in Beijing today.
洞察:
AstraZeneca plc announced on Jan 29, 2026, that it would invest $15 billion in China 
CNthrough 2030 to expand medicines manufacturing and research and development. The pharmaceutical company described this expansion as its largest-ever investment in China, representing a significant strategic commitment to its second-biggest market. This announcement was made during British Prime Minister Keir Starmer keir starmer's visit to Beijing as part of efforts by the United Kingdom 
GBto strengthen ties with the nation.
CNthrough 2030 to expand medicines manufacturing and research and development. The pharmaceutical company described this expansion as its largest-ever investment in China, representing a significant strategic commitment to its second-biggest market. This announcement was made during British Prime Minister Keir Starmer keir starmer's visit to Beijing as part of efforts by the United Kingdom GBto strengthen ties with the nation.
